Insights from the SPARTAN Study
Ft. Drs. Jonathan Barratt and Shikha Wadhwani
Burden of Disease & Long-Term Impact
on Patients Ft. Dr. Jonathan Barrat
In this episode of the Rare Kidney Disease Show, Dr. Rovin, Professor of Internal
Medicine and Pathology at The Ohio State University and chair of the RKD
Scientific Network and Podcast, discusses advances in the management of IgAN
through a patient case study.
Also find us on:
Apple Podcasts
Spotify
Vimeo
Episode Summary
- Understanding the underlying IgAN pathophysiology: Highlight the 4-Hit Hypothesis and the intricate disease mechanism (Time Stamp)
- IgAN case study introduction (Time Stamp)
- Treatment initiation (Time Stamp)
- Management of progression: Question the outcomes of initial intervention for this patient (Time Stamp)
- Foundational therapy: Optimization for improved outcomes (Time Stamp)
- Maintenance options: Explore available therapies to sustain treatment effectiveness (Time Stamp)
- Postulated algorithm: Discover an algorithm for inflammation management and proteinuria reduction (Time Stamp)
- Closing remarks: Gain insight into future episodes (Time Stamp)
MA-SP-24-0011
More Episodes Like This
From Podocyte to Patient
The Pathophysiology of FSGS
Introduction to FSGS
Ft. Dr. Howard Trachtman
Contact Us
For more information, please click on the link below to be directed to our contact us form.
Adverse Event Reporting
To report suspected adverse reactions, contact Travere Therapeutics at 1-877-659-5518 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.